Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/158950| Title: | The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules |
| Author: | de la Torre, Beatriz G. Albericio Palomera, Fernando |
| Keywords: | Disseny de medicaments Pèptids Farmacologia Drug design Peptides Pharmacology |
| Issue Date: | 27-Feb-2017 |
| Publisher: | MDPI |
| Abstract: | This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules. |
| Note: | Reproducció del document publicat a: https://doi.org/10.3390/molecules22030368 |
| It is part of: | Molecules, 2017, vol. 22, num. 3, p. 368 |
| URI: | http://hdl.handle.net/2445/158950 |
| Related resource: | https://doi.org/10.3390/molecules22030368 |
| ISSN: | 1420-3049 |
| Appears in Collections: | Articles publicats en revistes (Química Inorgànica i Orgànica) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 681089.pdf | 1.45 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
